Larx Apex LP is a hedge fund based in San Juan, Puerto Rico. According to its most recent Form D, filed Sep 9, 2026, the fund has sold $4,812,057 of interests to 5 investors since its first sale in Oct 2024. The minimum investment it accepts from an outside investor is $250,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Brandon Spruill.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $4,812,057Cumulative sales reported on Form D
- Investors
- 5
- First sale
- Oct 1, 2024
- Minimum investment
- $250,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Brandon Spruill
- Latest Form D
- Sep 9, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Larx Apex LP
What is the minimum investment for Larx Apex LP?
According to its latest Form D, filed Sep 9, 2026, the minimum investment Larx Apex LP accepts from an outside investor is $250,000.
Who can invest in Larx Apex LP?
Larx Apex LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Larx Apex LP raised?
Larx Apex LP reports $4,812,057 sold from 5 investors on its Form D filed Sep 9, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Larx Apex LP based?
Larx Apex LP is based in San Juan, Puerto Rico.
When did Larx Apex LP launch?
Larx Apex LP reports its first sale in Oct 2024, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 46% of the 39 hedge funds based in Puerto Rico, and more than 14% of all 10,307 that report sales.